By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quest Diagnostics has teamed up with Beth Israel Deaconess Medical Center and Weill Cornell Medical College to launch a molecular blood test for identifying renal organ transplant rejection.

Quest has also formed R&D collaboration deals with Beth Israel Deaconess and Weill Cornell in the area of renal transplantation, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.